Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This synopsis reviews key dermatological advancements discussed at the British Association of Dermatologists meeting in 2011 and reports no new clinical results.

In this study, dermatologists in Spain reported a shift in androgenetic alopecia treatment practices from 2019-2020 to 2024, with increased prescribing of oral minoxidil and oral dutasteride, and changes in antiandrogen choices for different patient groups.

In this survey, dermatologists in India reported preferring alcohol-free minoxidil combined with procapil and finasteride over traditional alcohol-based formulations for managing androgenetic alopecia, citing better tolerance and patient adherence.

This survey found that healthcare professionals view a novel nutritional supplement containing a natural DHT inhibitor as a beneficial adjuvant in the treatment of androgenetic alopecia among Indians.

In this paper, three cases illustrate the diagnostic challenges of distinguishing between scarring and non-scarring alopecia, emphasizing the importance of thorough examinations and pathological evaluation to accurately diagnose hair disorders and initiate timely treatment.

This study suggests that establishing international consensus guidelines for including concealed or sensitive sites in routine forensic examinations is crucial to clarify clinician responsibilities, guide patient expectations, and reduce potential medicolegal issues.

A combined medical and aesthetic approach is crucial for effectively managing PCOS and its skin-related issues.

Adequate vitamin D is crucial for skin health and should be considered in dermatology.

This study found that general practitioners' diagnostic accuracy for skin conditions aligned with histological diagnosis in 24% of cases, whereas dermatologists achieved 77% concordance.

This review discusses hairstyling practices in the black community linked to traction alopecia, categorizes them by risk, and offers guidance for dermatologists on management and patient education but reports no new clinical results.

This review discusses the relationship between vitamin D and various skin diseases, highlighting recent findings on its role and the importance of assessing and correcting vitamin D levels, but reports no new clinical results.

This review suggests that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have potential benefits for dermatologic conditions but may also cause adverse skin reactions and impact surgical outcomes.

In this review, cosmetic practices such as non-ablative lasers, autologous fat injections, and oral isotretinoin may help alleviate certain symptoms of frontal fibrosing alopecia, while treatments like deep chemical peels and ablative laser therapies are contraindicated due to potential scarring risks.

This article highlights the gap between medically necessary dermatologic gender-affirming procedures and insurance coverage for transgender and gender diverse service members in the US Military, and discusses how dermatologists can support gender-affirming care and address existing healthcare disparities.

This review discusses the role of Demodex mites in ocular demodecosis and various eye ailments, highlighting diagnostic methods but noting a lack of standardized treatments, with no new clinical results reported.

This commentary discusses platelet-rich plasma for androgenetic alopecia but reports no new research findings.

Platelet-rich plasma may help with hair loss from androgenetic alopecia.

This article presents a clinical approach to diagnosing and managing hirsutism from a dermatological perspective, but it reports no new clinical findings.

This review discusses the association between certain dermatological diseases and increased cardiovascular risk, highlighting the need for clinicians to address cardiovascular risk factors in these patients.

This review highlights bicalutamide as a promising oral therapy for female pattern hair loss, noting its safety, tolerability, and effectiveness in women with hyperandrogenic symptoms like acne and hirsutism, though further trials are needed to confirm its ideal dose and efficacy.

This study assessed the impact of a New York Times article on consumer interest in androgenetic alopecia treatments by surveying dermatologists about practice trends and analyzing online search data related to low dose oral minoxidil and hair loss from February 2022 to February 2023.

This review discusses the cutaneous side effects associated with vemurafenib and ipilimumab in metastatic melanoma treatment and emphasizes the importance of dermatologists in managing these skin eruptions; it reports no new clinical results.

This study reported that there are no standardized guidelines for managing testosterone-induced acne vulgaris and androgenic alopecia in transmasculine or non-binary individuals undergoing gender-affirming hormone therapy, highlighting gaps in dermatology trainees’ preparedness to care for this population.

This review discusses the use of follicular unit extraction and scalp micropigmentation in treating male pattern baldness, noting that scalp micropigmentation provides a non-surgical option to emulate natural hair appearance without downtime.